MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
MediGene Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.59M |
| December 31, 2022 | 7.545M |
| December 31, 2021 | 11.76M |
| December 31, 2020 | 21.15M |
| December 31, 2019 | 23.30M |
| December 31, 2018 | 18.63M |
| December 31, 2017 | 15.64M |
| December 31, 2016 | 11.94M |
| December 31, 2015 | 8.553M |
| December 31, 2014 | 9.062M |
| December 31, 2013 | 7.956M |
| December 31, 2012 | 8.565M |
| December 31, 2011 | 14.60M |
| December 31, 2010 | 16.88M |
| Date | Value |
|---|---|
| December 31, 2009 | 24.70M |
| December 31, 2008 | 38.90M |
| December 31, 2007 | 37.01M |
| December 31, 2006 | 25.48M |
| December 31, 2005 | 18.33M |
| December 31, 2004 | 17.98M |
| December 31, 2003 | 24.67M |
| December 31, 2002 | 33.24M |
| December 31, 2001 | 24.75M |
| December 31, 2000 | 12.68M |
| December 31, 1999 | 8.348M |
| December 31, 1998 | 4.591M |
| December 31, 1997 | 2.631M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| InflaRx NV | 29.03M |
| BioNTech SE | 2.376B |
| Immatics NV | 199.58M |
| Arrowhead Pharmaceuticals, Inc. | 585.26M |
| Oncolytics Biotech, Inc. | 13.31M |